"JN.1 Variant Dominates 86% of US COVID Cases, CDC Reports"

The CDC estimates that the JN.1 subvariant accounts for about 85.7% of COVID-19 cases in the United States as of Jan. 19, making it the most widely circulating variant of SARS-CoV-2 in the country and globally. There is currently no evidence that JN.1 causes more severe disease than other variants, and available vaccines are expected to increase protection against it. JN.1, classified as a "variant of interest" by the World Health Organization, has seen an increase from the estimated prevalence of 55% to 68% of cases in the U.S. as per the CDC's projections from Jan. 5.